Re-emerging from Melbourne’s marathon lockdown, Agnés decided to explore cosmetic injectables as “a bit of a pick-me-up”. This decision, made in a moment of spontaneity, soon spiraled into a troubling experience that highlighted the hidden dangers of such procedures.
Essential Insights on Cosmetic Injectables and Safety Concerns
- The widely utilized dissolving agent hyaluronidase remains unregulated and unapproved for cosmetic procedures, despite its common application.
- Research indicates that 20% of patients who had fillers dissolved reported experiencing adverse effects.
- Numerous patients suffering from complications related to fillers and the dissolving process feel isolated, often feeling overlooked by medical professionals.
Initially, Agnés did not give much thought to her choice. However, after receiving dermal lip fillers that did not meet her expectations, she opted for a dissolving procedure, which is becoming increasingly common. Unfortunately, the outcome was not what she envisioned, leading to severe complications.
Following the injection of 30 units of hyaluronidase into her lips and jaw, Agnés awoke to excruciating “bone-crushing pain.” The intensity of her discomfort prompted significant concern, leading her to seek emergency medical assistance.
In the emergency room, Agnés expressed fears of a potential stroke due to her alarming symptoms. She described her experience, stating, “I felt very sickly, almost as if I had been poisoned by something,” while sitting in her lounge room in Queensland.
She recounted, “My pupils were very dilated, and my heart rate was racing.” This overwhelming sensation of dread made her instinctively aware that something was seriously amiss following the treatment.
Upon returning home, after being told that her symptoms might be a reaction to the anesthetic, Agnés felt a lingering unease, which would soon escalate into a series of distressing health changes.
In the days and weeks that followed, this 33-year-old woman, previously enjoying good health, began to notice alarming changes in her body accompanied by increasing pain. Medical records indicated symptoms such as dry eyes, blurred vision, slurred speech, chest pain, and jaw ligament issues, yet the root cause remained elusive.
The absence of comprehensive research surrounding hyaluronidase has left medical professionals unable to definitively state whether the dissolving agent was responsible for her severe health deterioration.
Today, the filmmaker grapples with a long list of systemic ailments that she believes were triggered by the dissolving agent. These include permanent nerve damage, deteriorating connective tissues throughout her body, and an autoimmune disorder that remains undiagnosed by doctors.
The drug that Agnés received is traditionally used in eye surgeries and other medical applications to decompose connective tissues and to facilitate the distribution of anesthetics by enhancing the permeability of skin cell tissues.
Despite its extensive use in medical settings, its application in cosmetic procedures has not gained approval from Australia’s Therapeutic Goods Administration (TGA) or other international health regulatory organizations, categorizing its use as “off-label.”
The TGA clarified that “off-label” usage allows doctors discretion in how they utilize the drug, even without rigorous safety testing.
Consequently, this widely used drug remains unregulated within Australia’s rapidly expanding cosmetic surgery sector.
The absence of clear guidelines for the drug’s optimal application worldwide has led to patients receiving varying types and quantities of the enzyme during treatments.
Describing the Distressing Effects of Cosmetic Procedures
While some patients undergo cosmetic procedures without any notable side effects, the Australasian College of Cosmetic Surgery and Medicine has reported a concerning surge in patients experiencing complications following dissolving treatments, ranging from mild discomfort to severe health issues.
Due to the uncertainty surrounding the drug’s full ramifications, patients like Agnés often feel “medically gaslit” by healthcare providers, leading to a sense of isolation and frustration with an industry perceived to prioritize profit over patient welfare.
This issue is exacerbated by the inadequate informed consent protocols, as many practitioners fail to adequately warn patients about the potential risks and complications associated with dissolving treatments.
When Agnés investigated the composition and function of the dissolving product, she discovered that it acts catalytically to break down tissues, describing her experience as akin to “slowly being corroded by something.”
Another victim, Tina, shared her ongoing struggles after receiving 6 milligrams of hyaluronidase injected into her cheeks and temples for dissolving fillers seven years ago.
“I look in the mirror and I can see myself aging rapidly. My mother just turned 70 and we look pretty much the same,” the 48-year-old reflected.
Tina lamented, “I used to walk into a room and draw attention; now I keep my head down and hide from others. I even quit my job.”
She emphasized that the industry is driven by profit: “It takes just half an hour to inject someone and make a considerable profit – it’s easy money.”
Experiencing Medical Gaslighting: A Personal Account
Agnés shared her struggle with chronic illness, describing the debilitating fatigue and disturbing thoughts that have plagued her for the past two years.
She recounted the most distressing aspect of her ordeal: the overt medical gaslighting she experienced from numerous doctors throughout her journey.
During one emergency visit to a Melbourne hospital, a doctor dismissed her symptoms with the comment, “You’re still pretty, go home and get some rest.” This remark exemplified the lack of understanding and empathy she faced.
Many medical professionals dismissed her condition as mere dysmorphia, further isolating her and severing connections with her family and friends who were unable to comprehend her suffering.
She stated, “I was told directly that it wasn’t possible for my condition to be related to the injections, and that I must be experiencing other unrelated issues.”
The implications of such dismissive attitudes were deeply hurtful: “It was cruel and callous to suggest that my suffering wasn’t real. It felt like a way to label a woman as hysterical rather than acknowledging that the medical community simply didn’t have answers.”
Agnés emphasized that “medical gaslighting” not only damages the individual but also undermines the support systems surrounding them, causing fractures in relationships with family and friends.
Sienna Blake is a licensed aesthetic consultant and beauty writer specializing in cosmetic surgery advancements and non-invasive treatments. With a background in dermatology and over eight years of industry experience, Sienna is passionate about helping people achieve confidence through informed beauty decisions. She holds a Bachelor's degree in Health Sciences and regularly collaborates with top plastic surgeons to stay at the forefront of aesthetic innovations. Outside of her work, Sienna enjoys traveling, skincare research, and practicing Pilates.
